Bicarbonate

Bicarbonate

SCHEMBL6206881

CCCCOC1CCCCC1.O=C(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 4/20 0.50
EPHX1 P07099 2/20 0.42
NPC1 O15118 1/20 0.41
EPHX2 P34913 1/20 0.40
PPP5C P53041 1/20 0.40
ALDH1A1 P00352 2/20 0.38
HTT P42858 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27915053 0.90 NPC1 (0.48) NAAAEPHX1NPC1EPHX2ALDH1A1
SCHEMBL6378525 0.90 NPC1 (0.48) NAAAEPHX1NPC1EPHX2ALDH1A1
SCHEMBL6379896 0.90 NPC1 (0.48) NAAAEPHX1NPC1EPHX2ALDH1A1
SCHEMBL11940413 0.90 NPC1 (0.48) NAAAEPHX1NPC1EPHX2ALDH1A1
SCHEMBL192534 0.90 NPC1 (0.48) NAAAEPHX1NPC1EPHX2ALDH1A1
SCHEMBL9128366 0.90 NPC1 (0.48) NAAAEPHX1NPC1EPHX2ALDH1A1
Bicarbonate SCHEMBL11159896 0.88 NAAA (0.44) NAAAEPHX1NPC1ALDH1A1HTT
SCHEMBL191351 0.88 NPC1 (0.45) NAAAEPHX1NPC1EPHX2ALDH1A1
Ethylene Glycol SCHEMBL27967552 0.86 TSHR (0.45) NAAAEPHX1NPC1EPHX2ALDH1A1
Cyclohexanol SCHEMBL28733967 0.85 NAAA (0.42) NAAAEPHX1NPC1EPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597228-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2005-11-23 EP disclosed
WO-2004072025-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-08-26 WO disclosed